Reactome: A Curated Pathway Database
THIS SITE IS USED FOR CURATION AND TESTING
IT IS NOT STABLE, IS LINKED TO AN INCOMPLETE DATA SET, AND IS NOT MONITORED FOR PERFORMANCE. WE STRONGLY RECOMMEND THE USE OF OUR PUBLIC SITE

Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Name Email address

Details on Person Tuveson, David A

Class:IdPerson:6790247
_displayNameTuveson, David A
_timestamp2015-08-10 14:38:57
created[InstanceEdit:6790246] Rothfels, Karen, 2015-08-10
firstnameDavid A
initialDA
surnameTuveson
(author)[LiteratureReference:6790250] C-Raf is required for the initiation of lung cancer by K-Ras(G12D)
[LiteratureReference:6790256] Demonstration of a genetic therapeutic index for tumors expressing oncogenic BRAF by the kinase inhibitor SB-590885
[LiteratureReference:9674745] Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes
[LiteratureReference:9680560] Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors
[LiteratureReference:9761983] Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis
[LiteratureReference:9818754] Transcriptional Regulation by Nrf2
[Change default viewing format]
No pathways have been reviewed or authored by Tuveson, David A (6790247)